Proshare Advisors LLC

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-08
Total Holdings
2,081
Total Value
44301564608
Accession Number
0001085146-25-002761
Form Type
13F-HR
Manager Name
Proshare Advisors LLC
Data Enrichment
99% identified
2,051 identified30 unidentified

Holdings

2,081 positions
Manager:
Search and click to pin securities to the top
Blink Charging Co.
Shares:
20827(-23.1%)
Value:
$19.1M(-49.3%)
LEXICON PHARMACEUTICALS, INC.
Shares:
41162(-16.8%)
Value:
$19.0M(-48.1%)
Sunnova Energy International Inc.
Shares:
50208(-19.8%)
Value:
$18.7M(-91.3%)
ATOSSA THERAPEUTICS, INC.
Shares:
27381(-23.1%)
Value:
$18.4M(-45.2%)
Lineage Cell Therapeutics, Inc.
Shares:
38865(-6.6%)
Value:
$17.6M(-16.1%)
Caribou Biosciences, Inc.
Shares:
17810(-23.1%)
Value:
$16.3M(-55.9%)
DESTINATION XL GROUP, INC.
Shares:
10863(-28.0%)
Value:
$15.9M(-60.9%)
Ventyx Biosciences, Inc.
Shares:
13156(-23.1%)
Value:
$15.1M(-59.6%)
SES AI Corp
Shares:
28697(-21.8%)
Value:
$14.9M(-81.4%)
TScan Therapeutics, Inc.
Shares:
10626(-19.1%)
Value:
$14.7M(-63.3%)
Forge Global Holdings, Inc.
Shares:
25474(-22.4%)
Value:
$14.3M(-53.1%)
Rekor Systems, Inc.
Shares:
15952(-23.1%)
Value:
$14.1M(-56.3%)
Zura Bio Ltd
Shares:
10927(-21.4%)
Value:
$14.1M(-59.4%)
VERU INC.
Shares:
28595(-23.1%)
Value:
$14.0M(-42.1%)
Tevogen Bio Holdings Inc.
Shares:
12933(-11.9%)
Value:
$14.0M(-7.6%)
SUTRO BIOPHARMA, INC.
Shares:
21441(-20.5%)
Value:
$13.9M(-71.9%)
CHEGG, INC
Shares:
21798(-23.1%)
Value:
$13.9M(-69.5%)
RENOVARO INC.
Shares:
24571(-24.6%)
Value:
$13.3M(-51.0%)
Inozyme Pharma, Inc.
Shares:
14521(-18.4%)
Value:
$13.2M(-73.2%)
Pyxis Oncology, Inc.
Shares:
13361(-19.4%)
Value:
$13.1M(-49.3%)